← FDA Drug Approvals (Drugs@FDA)

ABACAVIR SULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2017-11-21

Drug application

FDA Application #

ANDA078119

Application type

Abbreviated New Drug Application (Generic)

Brand name

ABACAVIR SULFATE

Generic name

ABACAVIR

Active ingredients

ABACAVIR SULFATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

CIPLA

Manufacturer

Cipla USA Inc.

First approval

2017-11-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown